Welcome to the NASH blog
Our blog includes perspectives and information on maximizing employee health benefits, and the importance of transparent pricing and drug affordability to enable access to life-saving specialty medications for all patients.
What patients can do when specialty drugs are unaffordable
Specialty medications are transformative for people living with complex, chronic, and life-threatening conditions. From cancer and autoimmune diseases to multiple sclerosis and rare disorders, these therapies can be life-changing. But for millions...
Setting the record straight: specialty drug sourcing
Industry Developments Recently, NASH received a note from the payer industry regarding international sourcing compliance following a federal court case in Maryland. It is important to know that the court order and litigation are specific to certain...
Bending the Cost Curve on Soaring Specialty Drug Costs
According to a recent Mercer study, the total health benefit cost per employee is projected to rise 6.5% in 2026. This is the highest increase since 2010 even after accounting for cost-reduction measures. The two leading concerns for benefit...
Tackling Specialty Drug Affordability: Empowering Self-Insured Employers to Regain Control Over Specialty Pharmacy Spend
The specialty drug affordability issue Prescription drug use and spend has been steadily increasing in the U.S. and around the world. In fact, less than 5% of the U.S. population requires treatment with specialty drugs, yet they account for over...
How to increase employee engagement in pharmacy benefits
Summary Learn how employers can increase employee engagement in NASH programs through incentive programs like non-cash compensation, contests, and polypharmacy bundling. These strategies not only boost participation but also improve healthcare...
NASH can help navigate Florida’s Drug Importation Program
We are in an era where healthcare costs often soar sky-high. Ensuring affordable medications for patients is more important than ever. Florida is taking a significant step in that direction with the recent FDA authorization of its innovative drug...